Latest Period
Q2 2026
Security Snapshot
Oscar Health, Inc. - Class A Common Stock, par value $0.00001 per share (OSCR) Institutional Ownership
CUSIP: 687793109
13F Institutional Holders and Ownership History from Q1 2021 to Q2 2026
Institutions Reporting
399
Shares (Excl. Options)
197,886,148
Price
$28.52
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Class A Common Stock, par value $0.00001 per share
- Symbol
- OSCR on NYSE
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 197,886,148
- Total 13F value
- $5,644,942,584
- Portfolio coverage rank
- 0.01%
- Share change
- +23,878,929
- Value change
- +$786,033,225
- Number of holders
- 399
- Shares outstanding
- 224,919,027
- SEC-reported price per share
- $29.10
- Insider filing price
- $29.10
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- OSCR - Oscar Health, Inc. - Class A Common Stock, par value $0.00001 per share is tracked under CUSIP 687793109.
- 399 institutions reported positions in Q2 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 328 to 399 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $2,002,407,279 to $5,644,942,584.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 399 institutions filings for Q2 2026.
Security key
687793109
Latest holder period
Q2 2026
13F holders
399
13D/G owners
4
CIK / CUSIP context first
Open Q2 2026 holders
OSCR full holder history
Oscar Health, Inc. SEC filings
Oscar Health, Inc. company facts
Oscar Health, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 687793109:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
OSCR
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 6.4% | $298,910,284 | 13,941,711 | BlackRock, Inc. | 30 Jun 2025 | |||
| JPMORGAN CHASE & CO | 4.5% | -32% | $143,092,346 | -$55,508,727 | 9,950,789 | -28% | JPMORGAN CHASE & CO. | 30 Jun 2025 |
| T. Rowe Price Investment Management, Inc. | 3.7% | $157,535,536 | 8,322,004 | T. Rowe Price Investment Management, Inc. | 30 Sep 2025 | |||
| Dragoneer Investment Group, LLC | 0.3% | $11,426,220 | 657,435 | Marc Stad | 31 Dec 2025 |
As of 30 Jun 2026, 399 institutional investors reported holding 197,886,148 shares of Oscar Health, Inc. - Class A Common Stock, par value $0.00001 per share (OSCR). This represents 88% of the company’s total 224,919,027 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
65%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 9.2% | 20,587,428 | +19% | 0.01% | $587,153,449 |
| T. Rowe Price Investment Management, Inc. | 5.8% | 13,035,486 | +12% | 0.24% | $371,773,000 |
| D. E. Shaw & Co., Inc. | 5.6% | 12,643,617 | +131% | 0.22% | $360,595,957 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.9% | 11,029,424 | +4.6% | 0.01% | $314,559,172 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.7% | 10,579,437 | -1.8% | 0.01% | $301,725,543 |
| AMERICAN CENTURY COMPANIES INC | 4% | 9,055,242 | +29% | 0.11% | $258,255,502 |
| JANE STREET GROUP, LLC | 2.8% | 6,365,039 | +119% | 0.12% | $181,530,912 |
| Thrive Capital Management, LLC | 2.8% | 6,343,617 | 0% | 4.7% | $180,919,957 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.6% | 5,819,186 | +16% | 0.01% | $165,994,311 |
| STATE STREET CORP | 2.6% | 5,801,351 | +10% | 0% | $165,454,531 |
| FMR LLC | 2.2% | 4,998,523 | +317% | 0.01% | $142,557,861 |
| CITADEL ADVISORS LLC | 1.9% | 4,229,552 | +22% | 0.07% | $120,626,823 |
| TWO SIGMA INVESTMENTS, LP | 1.8% | 4,035,689 | +72% | 0.09% | $115,097,850 |
| DIMENSIONAL FUND ADVISORS LP | 1.6% | 3,571,731 | -15% | 0.02% | $101,885,043 |
| BIT Capital GmbH | 1.5% | 3,417,957 | -46% | 3.3% | $97,480,134 |
| RENAISSANCE TECHNOLOGIES LLC | 1.5% | 3,284,500 | 0.13% | $93,673,940 | |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.4% | 3,255,724 | +70% | 0.01% | $92,855,000 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.3% | 3,025,316 | +22% | 0.31% | $86,282,012 |
| GLYNN CAPITAL MANAGEMENT LLC | 1.1% | 2,575,828 | -0.62% | 20% | $73,462,615 |
| GOLDMAN SACHS GROUP INC | 1% | 2,289,557 | +56% | 0.01% | $65,298,165 |
| NORTHERN TRUST CORP | 0.98% | 2,211,209 | +18% | 0.01% | $63,063,680 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.94% | 2,119,863 | +12% | 0.01% | $60,458,493 |
| MORGAN STANLEY | 0.94% | 2,114,280 | -37% | 0% | $60,299,272 |
| Nuveen, LLC | 0.79% | 1,770,745 | +34% | 0.01% | $50,501,648 |
| BNP PARIBAS FINANCIAL MARKETS | 0.76% | 1,706,196 | 0% | 0.03% | $48,660,710 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
22
Latest
Q2 2026
Rows shown
1-22 of 22
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 197,886,148 | $5,644,942,584 | +$786,033,225 | $28.52 | 399 |
| 2026 Q1 | 174,290,962 | $2,002,407,279 | -$1,550,369 | $11.47 | 328 |
| 2025 Q4 | 168,569,629 | $2,422,621,495 | +$226,271,692 | $14.37 | 342 |
| 2025 Q3 | 149,792,205 | $2,835,618,710 | -$426,363,004 | $18.93 | 335 |
| 2025 Q2 | 168,548,889 | $3,611,647,706 | -$289,634,922 | $21.44 | 323 |
| 2025 Q1 | 186,598,634 | $2,446,656,406 | -$110,044,429 | $13.11 | 285 |
| 2024 Q4 | 194,956,941 | $2,621,590,374 | +$146,853,067 | $13.44 | 257 |
| 2024 Q3 | 178,386,882 | $3,782,103,219 | +$110,762,194 | $21.21 | 279 |
| 2024 Q2 | 172,745,011 | $2,733,174,271 | +$252,278,335 | $15.82 | 258 |
| 2024 Q1 | 156,903,935 | $2,334,180,594 | +$193,138,229 | $14.87 | 215 |
| 2023 Q4 | 150,724,824 | $1,379,131,654 | -$3,785,138 | $9.15 | 186 |
| 2023 Q3 | 147,067,613 | $819,530,306 | -$7,326,284 | $5.57 | 175 |
| 2023 Q2 | 148,010,019 | $1,192,835,277 | +$5,911,074 | $8.06 | 161 |
| 2023 Q1 | 147,482,265 | $964,531,497 | +$66,794,321 | $6.54 | 130 |
| 2022 Q4 | 139,544,348 | $343,274,000 | -$14,475,084 | $2.46 | 129 |
| 2022 Q3 | 146,909,762 | $733,091,997 | +$22,710,896 | $4.99 | 129 |
| 2022 Q2 | 142,413,972 | $605,294,235 | -$91,989,720 | $4.25 | 126 |
| 2022 Q1 | 143,850,142 | $1,434,295,239 | +$18,060,433 | $9.97 | 122 |
| 2021 Q4 | 130,976,699 | $1,028,199,597 | +$32,022,110 | $7.85 | 107 |
| 2021 Q3 | 125,835,387 | $2,183,281,915 | -$105,326,121 | $17.39 | 87 |
| 2021 Q2 | 128,494,559 | $2,769,676,759 | -$63,986,538 | $21.50 | 75 |
| 2021 Q1 | 136,426,375 | $3,646,678,745 | +$3,332,048,743 | $26.88 | 88 |